Atovaquone-proguanil for treating uncomplicated malaria.

@article{OseiAkoto2005AtovaquoneproguanilFT,
  title={Atovaquone-proguanil for treating uncomplicated malaria.},
  author={Alex Osei-Akoto and L Orton and Shirley Owusu-Ofori},
  journal={The Cochrane database of systematic reviews},
  year={2005},
  volume={4},
  pages={
          CD004529
        }
}
BACKGROUND Many conventional treatments for uncomplicated malaria are failing because malaria parasites develop resistance to them. One way to combat this resistance is to treat people with a combination of drugs, such as atovaquone-proguanil. OBJECTIVES To compare atovaquone-proguanil with other antimalarial drugs (alone or in combination) for treating children and adults with uncomplicated Plasmodium falciparum malaria. SEARCH STRATEGY We searched the Cochrane Infectious Diseases Group… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 18 CITATIONS

Atovaquone oral bioavailability enhancement using electrospraying technology

VIEW 1 EXCERPT
CITES BACKGROUND

Antimalarial pharmacology and therapeutics of atovaquone

Advances in the Treatment of Malaria

VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-9 OF 9 REFERENCES

Data from graphs. Appendix 3. Parasite clearance time: median and range Trial

  • Vietnam Giao
  • 2004
VIEW 27 EXCERPTS
HIGHLY INFLUENTIAL

Methods Randomized controlled trial

  • De Alencar
  • 1997
VIEW 22 EXCERPTS
HIGHLY INFLUENTIAL

Characteristics of included studies [ordered by study ID

  • 1999

Mookmanee D, et al.Efficacy and pharmacokinetics of atovaquone and proguanil in children with multidrug-resistant Plasmodium falciparum malaria

  • P Attanath, P Phanuaksook, P Chanthavanich, Y Poonpanich
  • Sabchareon
  • 1998